UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 284

Sortiert nach

LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling

Nature communications, 2019-06, Vol.10 (1), p.2571-17, Article 2571

2019

Volltextzugriff (PDF)

Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine

Molecular cancer, 2020-12, Vol.19 (1), p.171-18, Article 171

2020

Volltextzugriff (PDF)

The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer

Nature communications, 2020-06, Vol.11 (1), p.2689-14, Article 2689

2020

Volltextzugriff (PDF)

Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer

Oncogene, 2020-10, Vol.39 (42), p.6556-6571

2020

Volltextzugriff (PDF)

Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer

Oncogene, 2019-06, Vol.38 (24), p.4875-4884

2019

Volltextzugriff (PDF)

Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression

European urology, 2017-11, Vol.72 (5), p.835-844

2017

Volltextzugriff (PDF)

BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts

International journal of oncology, 2015-08, Vol.47 (2), p.719-727

2015

Volltextzugriff (PDF)

Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death

Cancer treatment reviews, 2014-02, Vol.40 (1), p.31-40

2014

Volltextzugriff (PDF)

Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma

Nature communications, 2017-10, Vol.8 (1), p.918-15, Article 918

2017

Volltextzugriff (PDF)

YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression

Journal of experimental & clinical cancer research, 2020-02, Vol.39 (1), p.36-16, Article 36

2020

Volltextzugriff (PDF)

Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies

PloS one, 2014-09, Vol.9 (9), p.e107516

2014

Volltextzugriff (PDF)

Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression

Cell death & disease, 2019-01, Vol.10 (2), p.37-37, Article 37

2019

Volltextzugriff (PDF)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer

Asian Journal of Urology, 2020-07, Vol.7 (3), p.203-218

2020

Volltextzugriff (PDF)

CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model

BMC cancer, 2024-01, Vol.24 (1), p.148-148, Article 148

2024

Volltextzugriff (PDF)

Detection of circulating tumor cells in prostate cancer based on carboxylated graphene oxide modified light addressable potentiometric sensor

Biosensors & bioelectronics, 2015-04, Vol.66, p.24-31

2015

Volltextzugriff (PDF)

Development and validation of a nomogram to predict recurrence for clinical T1/2 clear cell renal cell carcinoma patients after nephrectomy

BMC surgery, 2024-06, Vol.24 (1), p.1-11, Article 196

2024

Volltextzugriff (PDF)

Chromatin accessibility dynamics dictate renal tubular epithelial cell response to injury

Nature communications, 2022-11, Vol.13 (1), p.7322-7322, Article 7322

2022

Volltextzugriff (PDF)

KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells

Disease markers, 2019-01, Vol.2019, p.4863182-9

2019

Volltextzugriff (PDF)

Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization

Frontiers in genetics, 2024-05, Vol.15, p.1392745-1392745

2024

Volltextzugriff (PDF)

Prognostic implication and immunotherapy response prediction of a costimulatory molecule signature in kidney renal clear cell carcinoma

Immunogenetics (New York), 2022-06, Vol.74 (3), p.285-301

2022

Volltextzugriff (PDF)

The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer

Cell death & disease, 2020-09, Vol.11 (9), p.807-807, Article 807

2020

Volltextzugriff (PDF)

Risk Factors and Prevention of Inguinal Hernia After Radical Prostatectomy: A Systematic Review and Meta-Analysis

The Journal of urology, 2013-03, Vol.189 (3), p.884-890

2013

Volltextzugriff (PDF)

The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis

Journal of experimental & clinical cancer research, 2019-09, Vol.38 (1), p.386-386, Article 386

2019

Volltextzugriff (PDF)

Generation and Analysis of Pyroptosis-Based and Immune-Based Signatures for Kidney Renal Clear Cell Carcinoma Patients, and Cell Experiment

Frontiers in genetics, 2022-02, Vol.13, p.809794-809794

2022

Volltextzugriff (PDF)

C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion

Neoplasia (New York, N.Y.), 2017-02, Vol.19 (2), p.135-144

2017

Volltextzugriff (PDF)

1 – 25 von 284

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(256)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(194)
Life Sciences & Biomedicine
(156)
Humans
(105)
Prostate Cancer
(81)
Male
(79)
Oncology
(77)
Cell Line, Tumor
(50)
Animals
(49)
Mice
(38)
Tumors
(38)
Androgens
(35)
Metastasis
(32)
Urology & Nephrology
(31)
Cell Biology
(29)
Prostatic Neoplasms - Pathology
(29)
Cell Proliferation
(28)
Prognosis
(27)
Science & Technology - Other Topics
(25)
Cancer Therapies
(23)
Meta-Analysis
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Translational Andrology And Urology
(25)
Journal Of Clinical Oncology
(12)
Oncotarget
(12)
Cell Death & Disease
(11)
The Journal Of Urology
(11)
Cell Death And Disease
(10)
Oncogene
(8)
Plos One
(8)
The Prostate
(8)
Tumor Biology
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling

Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine

The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer

Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer

Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer

Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression

BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts

Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death

Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma

YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression

Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies

Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer

CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model

Detection of circulating tumor cells in prostate cancer based on carboxylated graphene oxide modified light addressable potentiometric sensor

Development and validation of a nomogram to predict recurrence for clinical T1/2 clear cell renal cell carcinoma patients after nephrectomy

Chromatin accessibility dynamics dictate renal tubular epithelial cell response to injury

KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells

Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization

Prognostic implication and immunotherapy response prediction of a costimulatory molecule signature in kidney renal clear cell carcinoma

The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer

Risk Factors and Prevention of Inguinal Hernia After Radical Prostatectomy: A Systematic Review and Meta-Analysis

The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis

Generation and Analysis of Pyroptosis-Based and Immune-Based Signatures for Kidney Renal Clear Cell Carcinoma Patients, and Cell Experiment

C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion

Suchergebnisse filtern